A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis - Wikidata - wikimedia - TriplyDB

A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis

A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis

http://www.wikidata.org/entity/Q37231292

about

Constitutive activation of epithelial TLR4 augments inflammatory responses to mucosal injury and drives colitis-associated tumorigenesis Pattern Recognition Receptors in Cancer Progression and Metastasis Decreased eccentric exercise-induced macrophage infiltration in skeletal muscle after supplementation with a class of ginseng-derived steroids Comparison of Cellular Uptake and Inflammatory Response via Toll-Like Receptor 4 to Lipopolysaccharide and Titanium Dioxide Nanoparticles Inflammatory bowel disease Microbial fingerprinting detects intestinal microbiota dysbiosis in Zebrafish models with chemically-induced enterocolitis.Pathogen recognition receptors, cancer and inflammation in the gut.Intestinal stem cells and their roles during mucosal injury and repair.Role of gut microbiota in a zebrafish model with chemically induced enterocolitis involving toll-like receptor signaling pathways.Toll-like receptor 4 in inflammation and angiogenesis: a double-edged sword.Toll-like receptors in inflammatory bowel diseases: a decade later.Intestinal inflammation and mucosal barrier function.Host-microbiota interaction and intestinal stem cells in chronic inflammation and colorectal cancer.DNA attenuates enterocyte Toll-like receptor 4-mediated intestinal mucosal injury after remote trauma.Antimicrobial peptides and gut microbiota in homeostasis and pathology.Worms, flies and four-legged friends: the applicability of biological models to the understanding of intestinal inflammatory diseases.Innate immune activation by tissue injury and cell death in the setting of hematopoietic stem cell transplantation.How the Intricate Interaction among Toll-Like Receptors, Microbiota, and Intestinal Immunity Can Influence Gastrointestinal Pathology Lipopolysaccharides: from Erinyes to Charites Protective Role of β-arrestin2 in Colitis Through Modulation of T-cell Activation.Differentiating functional roles of gene expression from immune and non-immune cells in mouse colitis by bone marrow transplantation Corticotropin-Releasing Hormone Receptor 2 Signaling Promotes Mucosal Repair Responses after Colitis.Intestinal alkaline phosphatase inhibits the proinflammatory nucleotide uridine diphosphate Formylpeptide receptor-2 contributes to colonic epithelial homeostasis, inflammation, and tumorigenesis.Signal relay by CC chemokine receptor 2 (CCR2) and formylpeptide receptor 2 (Fpr2) in the recruitment of monocyte-derived dendritic cells in allergic airway inflammation Innate immune signaling in the pathogenesis of necrotizing enterocolitis.Toll-like receptors as therapeutic targets for autoimmune connective tissue diseases Protective effect of naringenin against experimental colitis via suppression of Toll-like receptor 4/NF-κB signalling The role of pattern recognition receptors in intestinal inflammation.Paeoniflorin abrogates DSS-induced colitis via a TLR4-dependent pathway.The role of TLRs, NLRs, and RLRs in mucosal innate immunity and homeostasis.Toll-like receptors as therapeutic targets in gastrointestinal diseases.Modulation of toll-like receptor function has therapeutic potential in autoimmune disease.Toll-like receptor modulators: a patent review (2006-2010).Role of the microbiota in inflammatory bowel diseases.Acute kidney injury: a conspiracy of Toll-like receptor 4 on endothelia, leukocytes, and tubules.Modulating immunity as a therapy for bacterial infections.Innate immune responses in the CNS: role of toll-like receptors, mechanisms, and therapeutic opportunities in multiple sclerosis.Role of high-mobility group box 1 protein in inflammatory bowel disease.Inhibition of Toll-Like Receptor Signaling as a Promising Therapy for Inflammatory Diseases: A Journey from Molecular to Nano Therapeutics.

P2860

Q24611771-9331679D-8885-4723-B3A3-32A1B81ABEA8 Q26798034-22C46609-A0DB-440B-835F-14479080CBE2 Q28542680-EA4437C5-736C-4B98-9468-5CEF0638E143 Q29248679-56742DA2-A32A-4805-A752-56634BF3F155 Q29615500-49EBB254-A7A1-479D-9980-A3B927D358E4 Q33643059-4FC5ACE9-185F-49D2-AC33-5E07DC5A76F0 Q33680511-7D82C982-663B-4AA7-9CA9-F90F83EA59A4 Q33692786-63D05C7B-D5CE-4D3D-AE65-370E99D2FBCF Q33731168-3857D18A-ACE7-4EBD-9D64-2FF41FEF1EA4 Q33851340-396195D5-4E4F-4E1C-ADE3-8E9C567791FB Q34134813-05A59EAE-80A9-4D6D-B76D-C2B48BCC9D51 Q34438743-186D54FA-6A7E-4A83-8772-B23C34C65588 Q34698758-9014071C-563E-4FF7-8BE5-0181D27E97AD Q34979970-5BF00C9F-7FE0-4D95-8F07-05227A9F02A5 Q34987870-FA5232B9-0070-42D9-886B-B95200355C1E Q35070715-75DA7594-BCD0-4FA7-81F8-0978A75B6145 Q35179622-1158FB7E-319C-47C0-A8F8-F8D4AE37ABB7 Q35668249-21FC09AD-484D-4C51-B098-81041888AFD5 Q35991141-E679916B-56A8-4BCD-92FD-BB4C210BEB27 Q36303508-91044560-A700-4E54-A19A-1300FC933827 Q36375130-75145300-A673-4FB3-B92B-5969AF03D33D Q36465772-CE4401B8-BAF4-4429-A962-2C322DA0994D Q36699737-240ED197-B101-4AFD-87C3-571409F429D2 Q36733448-A891D996-43A3-4F9B-92DF-6806363FA6F7 Q36910018-CFBF97A2-7D46-4DE0-A852-C4231C3405BE Q36914228-A615AAF5-A7C9-40E8-9C20-E506D01C7CD6 Q36940639-3CA785B6-7722-45A9-9CD8-D1628A773588 Q37053805-F200A296-D417-4D75-9BEC-F79B0BF1833E Q37062911-603D6DA6-E674-42C5-BC89-26F31ABA0972 Q37575684-944C559B-5FFA-436C-8DD0-710DA53B8A2A Q37627550-7A72CA37-9FE7-4F61-AAC8-581143C6C7C6 Q37690323-CFDD6BD0-37B8-4F44-81B9-3D6D00CC411B Q37805517-D1216FBF-C1DE-416A-86AE-7241079D2C4C Q37853197-4460ED65-11D6-461C-8F7E-272615F0C501 Q37936393-3CAD700C-F80A-4EB2-9EE1-655815E79789 Q37950251-9B0F7C0D-F8BE-4E12-97A3-1AEC1382C169 Q37994068-219AE21F-50DD-40E9-99CD-48D05B32E584 Q38118170-3C4A5828-CD8B-4997-8003-FCF3A4CF7926 Q38528453-319073DB-59CE-4CA0-B041-5369C5CC3ADC Q38557048-A4E7831E-F09D-4950-AEFF-4708DA3F15B8

P2860

A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis

http://www.wikidata.org/entity/Q37231292

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 09 April 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

A novel Toll-like receptor 4 a ...... osal healing in murine colitis

@en

A novel Toll-like receptor 4 a ...... sal healing in murine colitis.

@nl

type

label

A novel Toll-like receptor 4 a ...... osal healing in murine colitis

@en

A novel Toll-like receptor 4 a ...... sal healing in murine colitis.

@nl

prefLabel

A novel Toll-like receptor 4 a ...... osal healing in murine colitis

@en

A novel Toll-like receptor 4 a ...... sal healing in murine colitis.

@nl

P1433

Q37231292-0F75FA07-78B4-47C7-959F-06CE93423835

P1476

Q37231292-28F5D671-BAF6-4993-A613-7D03495E8266

P2093

Q37231292-1F6F5CB2-20C6-4E56-831A-F5F02A2B8125

Q37231292-27B73551-A85D-464E-8A77-22221AFD4406

Q37231292-316E2A6E-3DC6-4055-BB71-526F8A2F9F84

Q37231292-42F59665-31F0-468E-803A-32FCCF7CE0C8

Q37231292-431065A8-481F-4A30-BCF9-A9CFEEE82659

Q37231292-59A574E0-96D1-41FF-8908-092C55B78848

Q37231292-60B5EFF4-8810-42E2-A067-B5BFAA725CB4

Q37231292-7FB831AB-E3B8-40C7-AB87-9D3D216A1697

Q37231292-7FD9586D-BB76-4155-8F43-F6A4BD7E5F1D

Q37231292-BCF45E19-FAE7-4449-AA9E-DF141018A366

P2860

Q37231292-0967B81E-0A14-4E48-9031-BEC8EF2DCB7D

Q37231292-0BD9A071-ED94-43C1-9F82-D7D343F9A46D

Q37231292-105314ED-3E5B-4CA3-8FC6-1AA5A0DE872A

Q37231292-114BF19F-1898-42BA-BF81-F49D91E7AB62

Q37231292-14D4F36D-B08D-46A8-8AB3-28AFFE4D503F

Q37231292-192ECCDB-93FD-4C1F-8AD4-7DDC6DD7772A

Q37231292-1CCCC4D7-0061-4E9E-9C99-CA4D5F8635DB

Q37231292-1FB26148-3E4C-468F-AB7F-EB75489B0BED

Q37231292-207F91C1-8562-4298-A94A-04D1A0415E63

Q37231292-20A37013-C7AA-46A6-BFEB-EDE4924B42C5

P304

Q37231292-AE65F3E0-FD43-4D2A-8755-61A3743AACFA

P31

Q37231292-AC69972E-585C-4A26-80B4-8A44FDEC57A5

P356

Q37231292-5FDE2DB0-1BE5-4D0C-830E-A04F1DADDEAB

P433

Q37231292-01DB25B5-7789-454E-940C-E8B6718B27C4

P478

Q37231292-69D8B83D-642E-4E89-ABE7-4D533F3517E9

P577

Q37231292-3CF35F16-4D12-429E-AB84-4D88CEC4BDD9

P698

Q37231292-06BB6741-09AC-49AA-8264-F92CBFA08D4F

P921

Q37231292-87AAC42D-F80A-416B-B52A-7ABF799AA479

Q37231292-9592D079-5FFC-40FF-B283-2A6D48D9BA04

Q37231292-E46CB800-6CB5-4CAF-9ACB-65B76E2324F6

P932

Q37231292-2848E3FA-4E9A-4208-874B-33C2A5E26F83

P356

AJPGI.90496.2008

P1433

American Journal of Physiology - Gastrointestinal and Liver Physiology

P1476

A novel Toll-like receptor 4 a ...... osal healing in murine colitis

@en

P2093

Anli Chen

http://www.w3.org/2001/XMLSchema#string

Cecillia Espana

http://www.w3.org/2001/XMLSchema#string

David Hsu

http://www.w3.org/2001/XMLSchema#string

Greg Elson

http://www.w3.org/2001/XMLSchema#string

John Sotolongo

http://www.w3.org/2001/XMLSchema#string

Julia Zaias

http://www.w3.org/2001/XMLSchema#string

Keith Breglio

http://www.w3.org/2001/XMLSchema#string

Lloyd Mayer

http://www.w3.org/2001/XMLSchema#string

Maria T Abreu

http://www.w3.org/2001/XMLSchema#string

Marie Kosco-Vilbois

http://www.w3.org/2001/XMLSchema#string

P2860

Inflammatory Bowel Disease

The gut flora as a forgotten organ

Patients with active inflammatory bowel disease lack immature peripheral blood plasmacytoid and myeloid dendritic cells

Fractalkine induces chemotaxis and actin polymerization in human dendritic cells

Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4

Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis

MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways

TLR4 links innate immunity and fatty acid-induced insulin resistance

Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors.

Increased expression of DC-SIGN+IL-12+IL-18+ and CD83+IL-12-IL-18- dendritic cell populations in the colonic mucosa of patients with Crohn's disease.

P304

G1167-79

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPGI.90496.2008

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

296

http://www.w3.org/2001/XMLSchema#string

P577

2009-04-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19359427

http://www.w3.org/2001/XMLSchema#string

P921

Toll-like receptor

P932

2697943

http://www.w3.org/2001/XMLSchema#string